Uniphyl and Left ventricular hypertrophy - a phase IV clinical study of FDA data

Summary:

Left ventricular hypertrophy is reported as a side effect among people who take Uniphyl (theophylline), especially for people who are female, 60+ old, also take Carbachol, and have Asthma.

The phase IV clinical study analyzes which people have Left ventricular hypertrophy when taking Uniphyl. It is created by eHealthMe based on reports of 3,071 people who have side effects when taking Uniphyl from the FDA, and is updated regularly.

What is Uniphyl?

Uniphyl has active ingredients of theophylline. eHealthMe is studying from 3,086 Uniphyl users. Check the latest studies of Uniphyl.

What is Left ventricular hypertrophy?

Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart) is found to be associated with 897 drugs and 756 conditions by eHealthMe. Check the latest studies of Left ventricular hypertrophy.

On Jul, 23, 2026

3,071 people reported to have side effects when taking Uniphyl.
Among them, 19 people (0.62%) have Left ventricular hypertrophy.

Could Uniphyl cause Left ventricular hypertrophy?

Among these 19 people:

What is the gender of people who have Left ventricular hypertrophy when taking Uniphyl? *

female: 100 %
male: 0.0 %

What is the age of people who have Left ventricular hypertrophy when taking Uniphyl? *

What are other drugs people take besides Uniphyl? *

What are other side effects people have besides Left ventricular hypertrophy? *

Wheezing (a high-pitched whistling sound made while you breath): 19 people, 100.00%
Hyperthyroidism (over activity of the thyroid gland): 19 people, 100.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 100.00%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 19 people, 100.00%
Cardiac Failure: 19 people, 100.00%
Chest X-Ray Abnormal: 19 people, 100.00%
Cholangitis (infection of the bile duct): 19 people, 100.00%
Choledocholithiasis (stones in the common bile duct): 19 people, 100.00%
Chronic Kidney Disease: 19 people, 100.00%
Drug Ineffective: 19 people, 100.00%

What are the existing conditions these people have? *

Asthma: 19 people, 100.00%
Sense Of Oppression (sense of heavy burden): 10 people, 52.63%

* Approximation only. Some reports may have incomplete information.

Do you take Uniphyl and have Left ventricular hypertrophy?

- Check whether Left ventricular hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Uniphyl:

Uniphyl (3,086 reports)

Browse all side effects of Uniphyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Left ventricular hypertrophy:

Left ventricular hypertrophy (897 drugs)

Browse all the conditions that are associated with Left ventricular hypertrophy:

Left ventricular hypertrophy (756 conditions)

Related publications that referenced our studies

Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on theophylline (the active ingredients of Uniphyl) and Uniphyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.